Xilio Therapeutics, Inc.
(NASDAQ : XLO)

( )
XLO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.46%171.990.7%$974.20m
ABBVAbbVie, Inc. 0.23%138.391.9%$830.09m
PFEPfizer Inc. 0.33%49.410.9%$827.44m
LLYEli Lilly & Co. 0.27%302.111.1%$748.15m
MRKMerck & Co., Inc. 0.36%87.510.7%$740.74m
BMYBristol-Myers Squibb Co. -0.25%71.941.0%$648.20m
SIGASIGA Technologies, Inc. 3.35%24.080.0%$426.68m
AZNAstraZeneca Plc -0.56%65.661.0%$379.33m
ALNYAlnylam Pharmaceuticals, Inc. -2.52%213.088.1%$235.19m
GSKGSK Plc 0.10%40.610.3%$218.07m
HZNPHorizon Therapeutics Plc 0.06%69.645.4%$197.90m
SGENSeagen Inc. 1.64%178.695.7%$191.83m
NVSNovartis AG 0.67%86.140.2%$174.54m
RGENRepligen Corp. 0.00%246.276.7%$155.75m
NVONovo Nordisk A/S -0.49%102.710.1%$152.17m

Company Profile

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.